Shang‐Heng Wu

Papers

Total Citations

H-Index

About

Dr. Shang-Heng Wu is a pioneering head and neck surgeon whose research centers on advancing transoral robotic surgery (TORS) for pharyngeal and laryngeal cancers. His major contributions include demonstrating the feasibility and oncologic safety of TORS for early-stage hypopharyngeal cancer—a notoriously difficult-to-treat site—and addressing the challenging issue of anterior commissure involvement in early glottic carcinoma. Dr. Wu’s landmark 2015 study on TORS for hypopharyngeal cancer (41 citations) was among the first to report outcomes for this organ-preserving approach, while his work on glottic carcinoma (24 citations) provided critical preliminary data on a previously underexplored application. His prospective medium-term study (2021, 12 citations) further expanded the field by evaluating neoadjuvant chemotherapy before TORS and the potential to spare adjuvant radiotherapy, directly impacting treatment de-escalation strategies. Collectively, his research has helped define the role of robotic surgery in head and neck oncology, offering patients less invasive options with preserved function. Dr. Wu’s work is essential reading for surgeons and researchers seeking to understand the evolving landscape of minimally invasive treatment for upper aerodigestive tract malignancies.